E. Vallee

发表

Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis test: a multicenter study

É. Carpentier, M. Dailloux, B. Drouillard, 1995, Journal of clinical microbiology.

Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase

J. Mohler, B. Fantin, Claude Carbón, 1990, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of four fluoroquinolones in an animal model of infected lung.

J. Pocidalo, E. Vallee, E. Bergogne-Bérézin, 1991, The Journal of antimicrobial chemotherapy.

Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia

M. Muffat‐Joly, J. Pocidalo, J. Bédos, 1991, Antimicrobial Agents and Chemotherapy.

Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent

J. Herbert, J. Maffrand, J. Necciari, 1993 .

Relationship between Capsular Type, Penicillin Susceptibility, and Virulence of Human Streptococcus pneumoniae Isolates in Mice

Claude Carbón, M. Muffat‐Joly, J. Bédos, 2000, Antimicrobial Agents and Chemotherapy.

In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model

J. Pocidalo, J. Bédos, E. Vallee, 1994, Antimicrobial Agents and Chemotherapy.

Infections à Mycobacterium gordonae au cours de l'infection par le virus de l'immunodéficience humaine.

E. Vallee, A. Maresca, J. Coulaud, 1995 .

Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model

Claude Carbón, J. Bédos, E. Vallee, 1996, Antimicrobial agents and chemotherapy.

Pharmacodynamic activities of ciprofloxacin and sparfloxacin in a murine pneumococcal pneumonia model: relevance for drug efficacy.

M. Muffat‐Joly, J. Pocidalo, J. Bédos, 1998, The Journal of pharmacology and experimental therapeutics.

Inhibition of platelet phospholipase-A2 as a mechanism for the anti-aggregating effect of linoleic acid

M. Ageron, E. Vallee, J. Gougat, 1980, Agents and Actions.

Anti‐inflammatory and platelet anti‐aggregant activity of phospholipase‐A2 inhibitors

E. Vallee, J. Delahayes, J. Gougat, 1979, The Journal of pharmacy and pharmacology.

In vivo efficacy of cefotaxime and amoxicillin against penicillin-susceptible, penicillin-resistant and penicillin---cephalosporin-resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.

J. Bédos, E. Vallee, P. Moine, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Western blot analysis of antibody response to pneumococcal protein antigens in a murine model of pneumonia

P. Berche, J. Gaillard, E. Vallee, 1997, Clinical and diagnostic laboratory immunology.

Correlation between in vitro and in vivo activity of amoxicillin against Streptococcus pneumoniae in a murine pneumonia model.

J. Bédos, E. Vallee, J. Mazoit, 1997, The Journal of pharmacology and experimental therapeutics.

Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains

J. Bédos, E. Vallee, P. Moine, 1996, Antimicrobial agents and chemotherapy.

In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia

J. Pocidalo, J. Bédos, B. Veber, 1992, Antimicrobial Agents and Chemotherapy.

Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.

J. Pocidalo, J. Bédos, R. Swanson, 1991, The Journal of infectious diseases.

Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus.

A. Philippon, E. Vallee, E. Bergogne-Bérézin, 1988, The Journal of antimicrobial chemotherapy.